An anabolic bone stack anchored by the PTH-analogue teriparatide, with abaloparatide as the PTHrP alternative.
The two most established bone-anabolic peptides are teriparatide (a PTH 1-34 fragment, FDA-approved for osteoporosis) and abaloparatide (a PTHrP analogue, also approved). Both stimulate new bone formation rather than just slowing resorption.
They are alternatives, not a combination — both act on the PTH receptor, and the compound pages mark the pair as one to avoid running together — so this stack builds around teriparatide alone and names abaloparatide as the swap. Both are prescription osteoporosis drugs; this page is educational context, and bone-density treatment belongs with an endocrinologist.
| Compound | Role | Dose | Frequency |
|---|---|---|---|
| Teriparatide PTH 1-34 analogue; bone-anabolic, FDA-approved. | Primary | 20mcg daily (FDA-approved dose) | Once daily at same time each day |
Last updated . How this page was sourced is described in the methodology.